Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL576129

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COc1ccc(/C=C/C(=O)c2cc(OC)c(OC)c(OC)c2)cc1OCCO

Basic Information

ChEMBL ID CHEMBL576129
Phase Preclinical
Structure Type MOL
InChI Key ZXRVWYJQSCFWOG-FNORWQNLSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names

Molecular Properties

388.4
MW (Da)
2.99
ALogP
7
HBA
1
HBD
83.5
PSA (Ų)
0.49
QED
0
Ro5 Violations
10
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C21H24O7
MW 388.42
Aromatic Rings 2
Heavy Atoms 28
NP-Likeness 0.22

Activity Summary

IC50 1 meas. best 5.04

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
IC50 5.04 5.04 9100.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked IC50 = 9100.0 nM 5.04 Inhibition of TNFalpha induced NF-kappaB activation in human A549 cells by lucif... 19883086

Literature References

PubMed DOI Target Context # Activities
19883086 10.1021/jm901278z Unchecked 1
19883086 10.1021/jm901278z NCI-H2009 1
19883086 10.1021/jm901278z A549 1

Data from ChEMBL 36 via Core Engine